Literature DB >> 27399312

Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.

Janice Wing Mei Fung1, Sandra Bee Lay Lim2, Huili Zheng2, William Ying Tat Ho2, Bee Guat Lee2, Khuan Yew Chow2, Hin Peng Lee3.   

Abstract

AIM: To provide a comprehensive evaluation of the quality of the data at the Singapore Cancer Registry (SCR).
METHODS: Quantitative and semi-quantitative methods were used to assess the comparability, completeness, accuracy and timeliness of data for the period of 1968-2013, with focus on the period 2008-2012.
RESULTS: The SCR coding and classification systems follow international standards. The overall completeness was estimated at 98.1% using the flow method and 97.5% using the capture-recapture method, for the period of 2008-2012. For the same period, 91.9% of the cases were morphologically verified (site-specific range: 40.4-100%) with 1.1% DCO cases. The under-reporting in 2011 and 2012 due to timely publication was estimated at 0.03% and 0.51% respectively.
CONCLUSION: This review shows that the processes in place at the SCR yields data which are internationally comparable, relatively complete, valid, and timely, allowing for greater confidence in the use of quality data in the areas of cancer prevention, treatment and control.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Accuracy; Cancer registry; Comparability; Completeness; Data quality; Neoplasms; Timeliness; Validity

Mesh:

Year:  2016        PMID: 27399312     DOI: 10.1016/j.canep.2016.06.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

1.  Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.

Authors:  Tsai-Chung Li; Chia-Ing Li; Chiu-Shong Liu; Pao-Hsuan Lin; Wen-Yuan Lin; Chih-Hsueh Lin; Sing-Yu Yang; Jen-Huai Chiang; Cheng-Chieh Lin
Journal:  Oncotarget       Date:  2017-10-10

2.  Factors associated with false-positive mammography at first screen in an Asian population.

Authors:  Peh Joo Ho; Chek Mei Bok; Hanis Mariyah Mohd Ishak; Li Yan Lim; Jenny Liu; Fuh Yong Wong; Kee Seng Chia; Min-Han Tan; Wen Yee Chay; Mikael Hartman; Jingmei Li
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

3.  Long-term excess risk of breast cancer after a single breast density measurement.

Authors:  Matejka Rebolj; Oleg Blyuss; Kee Seng Chia; Stephen W Duffy
Journal:  Eur J Cancer       Date:  2019-06-21       Impact factor: 9.162

4.  Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.

Authors:  Peh Joo Ho; Fuh Yong Wong; Wen Yee Chay; Elaine Hsuen Lim; Zi Lin Lim; Kee Seng Chia; Mikael Hartman; Jingmei Li
Journal:  Cancer Med       Date:  2021-10-28       Impact factor: 4.452

5.  Active case-finding method improves completeness and accuracy of data reported to the rural Eastern Cape Cancer Registry in South Africa.

Authors:  Nontuthuzelo Im Somdyala; Linda Mbuthini; Borna Müller; Nomfuneko Sithole; Akhona Ncinitwa; Debbie Bradshaw
Journal:  Ecancermedicalscience       Date:  2021-06-17

Review 6.  Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland.

Authors:  Miriam Wanner; Katarina L Matthes; Dimitri Korol; Silvia Dehler; Sabine Rohrmann
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

7.  Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore.

Authors:  Peh Joo Ho; Hannah Si Hui Lau; Weang Kee Ho; Fuh Yong Wong; Qian Yang; Ken Wei Tan; Min-Han Tan; Wen Yee Chay; Kee Seng Chia; Mikael Hartman; Jingmei Li
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.